CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income	$ 51,507	$ 32,953	$ 33,413
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	24,507	22,890	21,117
Provision for credit losses	3,576	3,351	3,050
Stock-based compensation expense	7,806	6,520	7,703
Deferred income tax expense (benefit)	3,980	(698)	3,307
Amortization of intangibles	1,205	1,357	1,401
Amortization of debt issuance costs	512	622	699
Amortization and accretion of debt	563	539	515
Net loss on divestitures and impairment charges	371	2,580	1,191
Net gain on property damage, net of insurance claims	0	(417)	(343)
Net gain on sale of excess real property	(993)	0	(1,407)
Changes in operating assets and liabilities that provided (used) cash:
Accounts and preneed receivables	(28,151)	(24,620)	(8,122)
Inventories, prepaid, and other current assets	(1,687)	1,056	(72)
Intangible and other non-current assets	(3,547)	(4,402)	(3,246)
Preneed funeral and cemetery trust investments	(17,724)	1,390	(775)
Accounts payable	(369)	1,616	169
Accrued and other liabilities	(1,764)	3,590	2,988
Deferred preneed funeral and cemetery revenue	(1,752)	6,866	14,968
Deferred preneed funeral and cemetery receipts held in trust	22,653	(3,197)	(966)
Net cash provided by operating activities	60,693	51,996	75,590
Cash flows from investing activities:
Acquisitions of businesses and real property	59,026	0	44,500
Capital expenditures	(20,628)	(16,098)	(18,039)
Proceeds from divestitures and sale of other assets	44,483	12,057	4,132
Proceeds from insurance claims	0	403	1,403
Net cash used in investing activities	(35,171)	(3,638)	(57,004)
Cash flows from financing activities:
Borrowings from the credit facility	137,525	54,900	86,100
Payments against the credit facility	(147,825)	(97,000)	(97,700)
Payment of debt issuance costs for the credit facility	0	(781)	0
Payments on acquisition debt and obligations under finance leases	(1,116)	(1,061)	(1,167)
Proceeds from the exercise of stock options and employee stock purchase plan contributions	1,718	2,626	1,494
Taxes paid on restricted stock, performance award vestings, and exercise of stock options	(8,276)	(593)	(252)
Dividends paid on common stock	(7,025)	(6,807)	(6,708)
Net cash used in financing activities	(24,999)	(48,716)	(18,233)
Net increase (decrease) in cash and cash equivalents	523	(358)	353
Cash and cash equivalents at beginning of period	1,165	1,523	1,170
Cash and cash equivalents at end of period	1,688	1,165	1,523
Supplemental disclosure of cash flow information:
Cash paid for interest and financing costs	26,820	30,629	34,682
Cash paid for taxes	16,990	16,654	10,448
Land purchased in exchange for debt	$ 0	$ 0	$ 2,550